CD27-mediated signaling may promote memory- rather than effector-associated gene programs leading to improved tumor control35, consistent with findings that signaling through the CD70-CD27 axis may improve the efficacy and persistence of CAR T4. This evidence concerns the gene CD27 and neoplasm.